Cosmo Pharmaceuticals N.V.

LSE:0RGI Stock Report

Market Cap: CHF1.2b

Cosmo Pharmaceuticals Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Alessandro Della Cha

Chief executive officer

€1.4m

Total compensation

CEO salary percentage2.1%
CEO tenure10.1yrs
CEO ownershipn/a
Management average tenure6yrs
Board average tenure15.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Alessandro Della Cha's remuneration changed compared to Cosmo Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

€1m

Sep 30 2023n/an/a

€6m

Jun 30 2023n/an/a

€11m

Mar 31 2023n/an/a

€14m

Dec 31 2022€1m€30k

€17m

Sep 30 2022n/an/a

€26m

Jun 30 2022n/an/a

€35m

Mar 31 2022n/an/a

€28m

Dec 31 2021€2m€30k

€22m

Sep 30 2021n/an/a

€6m

Jun 30 2021n/an/a

-€11m

Mar 31 2021n/an/a

-€9m

Dec 31 2020€2m€30k

-€8m

Sep 30 2020n/an/a

-€7m

Jun 30 2020n/an/a

-€7m

Mar 31 2020n/an/a

-€16m

Dec 31 2019€3m€30k

-€24m

Sep 30 2019n/an/a

-€28m

Jun 30 2019n/an/a

-€31m

Mar 31 2019n/an/a

-€24m

Dec 31 2018n/an/a

-€18m

Sep 30 2018n/an/a

-€20m

Jun 30 2018n/an/a

-€23m

Mar 31 2018n/an/a

-€28m

Dec 31 2017€2m€30k

-€32m

Compensation vs Market: Alessandro's total compensation ($USD1.54M) is below average for companies of similar size in the UK market ($USD2.33M).

Compensation vs Earnings: Alessandro's compensation has been consistent with company performance over the past year.


CEO

Alessandro Della Cha (60 yo)

10.1yrs

Tenure

€1,434,862

Compensation

Mr. Alessandro E. Della Cha, LL M, served as Director at RedHill Biopharma Ltd. since February 01, 2021 until November 16, 2021.He has been the Chief Executive Officer of Cosmo Pharmaceuticals N.V. (forme...


Leadership Team

NamePositionTenureCompensationOwnership
Mauro Ajani
Founder & Executive Chairman18.3yrs€400.00kno data
Alessandro Della Cha
CEO & Executive Director10.1yrs€1.43mno data
Ngo Nhan
President of Cosmo Intelligent Medical Devicesno datano datano data
Giulio Evangelisti
SVP of Manufacturingno datano datano data
Niall Donnelly
Chief Financial Officer7.8yrsno datano data
Marco Lecchi
Chief Operating Officer3.3yrsno datano data
Davide Malavasi
Qualified Person & Technical Director12.6yrsno datano data
Luigi Longo
Chief Scientific Officer2yrsno datano data
Hazel Winchester
Head of Investor Relations2.3yrsno datano data
Biagio Vigano
Chief People Officer3.3yrsno datano data
Roberto Villa
Chief Manufacturing Officer27.3yrsno datano data
Andrea Cherubini
SVP of Science4.3yrsno datano data

6.0yrs

Average Tenure

51.5yo

Average Age

Experienced Management: 0RGI's management team is seasoned and experienced (6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mauro Ajani
Founder & Executive Chairman18.3yrs€400.00kno data
Alessandro Della Cha
CEO & Executive Director18.3yrs€1.43mno data
David Maris
Non-Executive Director2.9yrs€98.23kno data
Dieter Enkelmann
Non-Executive Director18.3yrs€98.23kno data
William Sandborn
Member of Scientific Advisory Boardno datano datano data
Simon P. Travis
Member of Scientific Advisory Boardno datano datano data
Geert D'Haens
Member of Scientific Advisory Boardno datano datano data
Silvio Danese
Member of Scientific Advisory Boardno datano datano data
Maria Roncarolo
Non-Executive Director12yrs€98.23kno data
Ralf Kiesslich
Member of Scientific Advisory Boardno datano datano data
Robert Steffen
Member of Scientific Advisory Boardno datano datano data
Kevin Donovan
Non-Executive Director8.1yrs€98.23kno data

15.1yrs

Average Tenure

64yo

Average Age

Experienced Board: 0RGI's board of directors are seasoned and experienced ( 15.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.